A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Dr Hanjing Xie Appointed New CMO of Neogap

What To Know

  • Hanjing Xie has over 25 years of experience from both the pharmaceutical industry, at companies such as Idogen, Oncopeptides, and Bayer, and from university hospitals and institutes, such as the Karolinska University Hospital, the Karolinska Institute, and St.
  • Xie is a highly experienced associate professor and senior consultant in oncology with diverse expertise from the pharmaceutical industry and university hospitals.

Neogap Therapeutics, a biotech company focused on developing personalised cancer immunotherapy, announced today the appointment of Dr. Hanjing Xie as its new Chief Medical Officer (CMO), starting from 21 March. Dr Hanjing Xie will oversee Neogap’s clinical development programs and pipeline and provide medical oversight for the company’s first-in-human study. Dr. Xie is a highly experienced associate professor and senior consultant in oncology with diverse expertise from the pharmaceutical industry and university hospitals.

Neogap Therapeutics recently received CTA approval for phase I/IIa clinical trial with its advanced cell therapy pTTL (personalised Tumour Trained Lymphocytes) cell therapy against colorectal cancer. The phase I/IIa trial is expected to begin in the first half of 2023.

Dr. Hanjing Xie has over 25 years of experience from both the pharmaceutical industry, at companies such as Idogen, Oncopeptides, and Bayer, and from university hospitals and institutes, such as the Karolinska University Hospital, the Karolinska Institute, and St. Göran’s hospital. She is an associate professor and senior consultant in oncology, holds a Ph.D. in clinical pharmacology, and has board certifications in clinical oncology, internal medicine, and hematology.

“We are thrilled to welcome Dr. Hanjing Xie as our new Chief Medical Officer. With extensive experience in research, clinical development, and patient care, Dr. Xie brings a wealth of expertise to Neogap. Her diverse background in the pharmaceutical industry and academia, along with specialised training in clinical oncology, and hematology, make her highly qualified to lead our cell therapy trial,” says Samuel Svensson, CEO of Neogap.

“As someone who has dedicated my career to finding new ways to fight cancer, I’m excited to join Neogap, a company that is at the forefront of personalised cancer immunotherapy. Working together with the experienced team at Neogap, I look forward to advancing innovative science and helping to increase survival rates for cancer patients by enhancing tumor-specific immune responses,” says Dr. Hanjing Xie.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”
Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.
Peter Eckes offers more than a 30-year career in the agricultural industry, and provides a unique appreciation for what it takes to bring innovation to the modern agriculture marketplace at scale without losing sight of farmer and consumer needs.

By using this website you agree to accept Medical Device News Magazine Privacy Policy